Acute Coronary Syndrome

My Settings
Relevant Content
Researchers at Heart
Dynamic Risk Trajectories for Sudden Cardiac Arrest: The Role of Recurrent Cardiovascular Events
Journal of the American Heart Association, Ahead of Print.
Background...
Impact of Revascularization Completeness on Cardiovascular Outcomes in STEMI With Multivessel Disease
Circulation: Cardiovascular Interventions, Ahead of Print.
BACKGROUND...
Ethical Considerations for Heart Organ Allocation Current Landscape and Future Policy Guidance
Ethical heart allocation demands equitable access, responsible stewardship...
Complete Revascularization in STEMI With MVD: Defined Intervention, But When Exactly?
Circulation: Cardiovascular Interventions, Ahead of Print.
Low‐Density Lipoprotein Cholesterol Lowering With Inclisiran Plus Usual Care in Recent Acute Coronary Syndrome: VICTORION‐INCEPTION, a Randomized, Controlled, Open‐Label Trial
Journal of the American Heart Association, Ahead of Print.
Background...
Methamphetamine Use Among Adult Patients Presenting With Acute Coronary Syndrome: A Single‐Center Retrospective Cohort Study
Journal of the American Heart Association, Ahead of Print.
Background...
Precision Antiplatelet Therapy: The Promise and Complexity of Pharmacogenomic Antiplatelet Therapy
Circulation: Cardiovascular Interventions, Ahead of Print.
Physical Activity in Pediatric Cardiomyopathies: Moving for Health
Physical activity supports cardiovascular fitness, social development, and...
Letter by Liu and Li Regarding Article, “Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke”
Circulation, Volume 153, Issue 14, Page e1107-e1108, April 7, 2026.